Brain volume loss linked to new Alzheimer’s immunotherapies, such as lecanemab, is caused by the removal of amyloid plaques rather than neuronal damage.

Designation underscores significant unmet need in frontotemporal dementia and the potential role of neflamapimod in multiple neurologic ...

Johns Hopkins researchers found that bats adapt to hearing loss using innate neural strategies, such as increasing ...

Dr. Mitchell Day is heading a team of OHIO scientists in an NIH-funded study aimed at uncovering the neural mechanisms behind ...

New research suggests previous assumptions about the pathogenesis of spinal muscular atrophy (SMA) are inadequate.

APOE4 carriers had higher blood-brain barrier permeability, even without cognitive decline or amyloid beta buildup, ...

In mice, dampening the activity of area postrema neurons diminished cancer-induced muscle and fat loss and increased lifespan ...

Researchers have identified that G-quadruplexes promote harmful protein aggregation in neurodegenerative diseases. Blocking ...

University of Sheffield spinout company, Rinri Therapeutics, a company focused on developing new treatments for hearing loss ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news ...

Abstract: This paper introduces a highly efficient electro-thermal coupling simulation method that leverages a data-driven neural network power loss model to enhance the simulation efficiency in the ...

Abstract: This paper introduces a novel method for estimating the path loss value in indoor scenarios. It uses a combination of electromagnetic calculation and machine learning. Using electromagnetic ...